GLP-1 Use Is Tilting Toward Weight Loss, and That Matters
New research highlighted by CBS News suggests GLP-1 medicines are increasingly being used for weight management, with implications for diabetes care, access, and expectations around these popular drugs.
When Cancer Drugs Run Short, Patients Feel the Gap
A Washington Post report describes how some U.S. cancer patients and clinicians are turning to overseas sources when key medicines run short. The broader pattern reflects a stubborn reality: shortages can delay treatment, force substitutions, and create new safety questions.
Canadian Mail-Order Prescriptions Face a New Hurdle
A U.S. customs change could make it harder and more expensive for some Americans to receive prescription medicines from Canada, raising fresh concerns about drug affordability and continuity of care.
When insurance delays hit COPD care, the stakes can be high
A reported death tied to delayed COPD medication highlights how coverage barriers can disrupt treatment for adults with chronic lung disease—especially after age 45.